Form D Explorer

Inspect source fieldsReport a record issue

Form D — NewcelX Ltd.

0001213900-25-062768 · filed Jul 10, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Pharmaceuticals filings

Offering

Industry
Pharmaceuticals
Exemptions
Rule 506(b)
Reported offering amount
$1,000,000
Reported amount sold
$1,000,000
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
NewcelX Ltd.
CIK
1783036
Entity
Other
Jurisdiction
SWITZERLAND
Year incorporated
—
Address
HOHSTRASSE 1
KLOTEN, Switzerland 8302
Phone
41 44 512 21 50

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Other filings from this issuer

View the original filing on SEC EDGAR ↗